| Literature DB >> 29343701 |
Bharati Pandey1, Sonam Grover2, Sukriti Goyal3, Anchala Kumari4, Aditi Singh4, Salma Jamal3, Jagdeep Kaur1, Abhinav Grover5.
Abstract
The enzyme Pantothenate synthetase (PS) represents a potential drug target in Mycobacterium tuberculosis. Its X-ray crystallographic structure has demonstrated the significance and importance of conserved active site residues including His44, His47, Asn69, Gln72, Lys160 and Gln164 in substrate binding and formation of pantoyl adenylate intermediate. In the current study, molecular mechanism of decreased affinity of the enzyme for ATP caused by alanine mutations was investigated using molecular dynamics (MD) simulations and free energy calculations. A total of seven systems including wild-type + ATP, H44A + ATP, H47A + ATP, N69A + ATP, Q72A + ATP, K160A + ATP and Q164A + ATP were subjected to 50 ns MD simulations. Docking score, MM-GBSA and interaction profile analysis showed weak interactions between ATP (substrate) and PS (enzyme) in H47A and H160A mutants as compared to wild-type, leading to reduced protein catalytic activity. However, principal component analysis (PCA) and free energy landscape (FEL) analysis revealed that ATP was strongly bound to the catalytic core of the wild-type, limiting its movement to form a stable complex as compared to mutants. The study will give insight about ATP binding to the PS at the atomic level and will facilitate in designing of non-reactive analogue of pantoyl adenylate which will act as a specific inhibitor for PS.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29343701 PMCID: PMC5772511 DOI: 10.1038/s41598-017-19075-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Plot showing the (A,B) RMSD, (C,D) RMSF for wild-type and six alanine mutants and (E) Ribbon representation showing superimposition of the pre-MD wild-type PanC homodimer (Chain A: orange, Chain B; Red) and post-MD simulation structure (Chain A: blue, Chain B; green).
Figure 2Plot showing backbone RMSD of wild-type and alanine mutant complexes during 50 ns MD simulation with respect to time (A) wild-type, H44A and H47A mutants; (B) wild-type, N69A and Q72A mutants; (C) wild-type, K160A and Q164A mutants. RMSF profile for each residue was depicted for (D) wild-type, H44A and H47A mutants; (E) wild-type, N69A and Q72A mutants; (F) wild-type, K160A and Q164A mutants.
RMSF value for the active site residues of wild-type and alanine mutants.
| Active site residues | M40 | H44 | H47 | N69 | Q72 | K160 | Q164 |
|---|---|---|---|---|---|---|---|
|
| |||||||
| Wild-type | 0.88 | 0.83 | 0.71 | 0.81 | 1.54 | 0.58 | 0.49 |
| H44A | 1.18 | 0.80 | 0.78 | 1.78 | 1.56 | 1.09 | 0.98 |
| H47A | 1.31 | 1.23 | 0.86 | 1.27 | 1.42 | 1.15 | 1.07 |
| N69A | 0.75 | 0.67 | 0.79 | 1.51 | 2.05 | 0.9 | 1.00 |
| Q72A | 1.09 | 0.94 | 0.76 | 1.62 | 2.80 | 1.06 | 1.15 |
| K160A | 1.34 | 0.89 | 0.72 | 1.86 | 2.49 | 1.20 | 1.10 |
| Q164A | 1.38 | 0.81 | 0.72 | 1.50 | 1.87 | 0.98 | 1.06 |
*Values are in Å.
Figure 3Radius of gyration profile for (A) wild-type, H44A and H47A mutants; (B) wild-type, N69A and Q72A mutants; (C) wild-type, K160A and Q164A mutants. Number of hydrogen bonds computed for (D) wild-type, H44A and H47A mutants; (E) wild-type, N69A and Q72A mutants; (F) wild-type, K160A and Q164A mutants.
Binding cavity size analysis for wild-type PS and alanine mutants.
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
| |||||||
| Volume (Å3) | 1717 | 1461.7 | 1665 | 1844.3 | 1870.3 | 1979.9 | 1889.6 |
| Area (Å2) | 1203.2 | 1000.4 | 1047.1 | 1370.6 | 1452.5 | 1108.3 | 1308.4 |
|
| |||||||
| Volume (Å3) | 1848.2 | 1153.5 | 1837.2 | 1721.4 | 1907.5 | 2297.2 | 1382.6 |
| Area (Å2) | 1318.7 | 1004 | 1295.2 | 1225 | 1202.5 | 1423.5 | 954.2 |
|
| |||||||
| Volume (Å3) | 1950.3 | 1639 | 1368.3 | 1762 | 1674 | 2015.1 | 1723 |
| Area (Å2) | 1316.8 | 1171 | 1009 | 1343.2 | 1268.2 | 1409.9 | 1218 |
|
| |||||||
| Volume (Å3) | 2025.5 | 2489.4 | 2830.4 | 2497 | 2285.6 | 2990.1 | 2149.8 |
| Area (Å2) | 1183.3 | 1619.6 | 1929.3 | 1788.7 | 1729.4 | 1912.6 | 1598.7 |
|
| |||||||
| Volume (Å3) | 1923.2 | 2131 | 2541.5 | 2628.4 | 2388.5 | 2592 | 2145.5 |
| Area (Å2) | 1639.7 | 1309 | 1691.4 | 1832.8 | 1516.4 | 1670.9 | 1353.2 |
|
| |||||||
| Volume (Å3) | 1742.6 | 2138.4 | 2527.9 | 2883.3 | 1827.4 | 1824.9 | 1750.6 |
| Area (Å2) | 1245.3 | 1370.3 | 1518.4 | 1568.3 | 1221.2 | 1107.3 | 1211.8 |
|
| |||||||
| Volume (Å3) | 1920.4 | 2015.6 | 2483.4 | 2529.7 | 2207.3 | 2493.7 | 2061.9 |
| Area (Å2) | 1168.4 | 1448.6 | 1538.2 | 1419.3 | 1559.5 | 1802 | 1335 |
Predicted experimental values and comparative binding free energies for wild-type and alanine mutants.
| Systems | Isothermal titration microcalorimetry results | MM-GBSA | ||||
|---|---|---|---|---|---|---|
| Ka(x104 M−1) | −∆G (kcal mol−1) | −∆H (kcal mol−1) | −T∆S (kcal mol−1) | Pre-MD (kcal mol−1) | Post-MD (kcal mol−1) | |
| Wild-type | 22.4 ± 1.6 | 7.3 | 14.2 ± 0.2 | 6.9 | −29.71 | −26.61 |
| H44A | — | — | — | — | −29.97 | −21.70 |
| H47A | 2.46 ± 0.11 | 6.0 | 7.2 ± 0.2 | 1.2 | −28.56 | −20.76 |
| N69A | 9.1 ± 0.4 | 6.8 | 13.0 ± 0.23 | 6.1 | −30.39 | −22.33 |
| Q72A | 13.2 ± 0.29 | 7.0 | 13.1 ± 0.46 | 6.2 | −32.00 | −27.28 |
| K160A | 0.45 ± 0.02 | 5.0 | 8.4 ± 0.3 | 3.4 | −25.24 | −17.93 |
| Q164A | 13.2 ± 0.29 | 7.0 | 17.3 ± 0.1 | 10.3 | −30.49 | −26.47 |
“—”: not predicted.
Figure 4Illustration of bonding interaction pattern in the (A) wild-type, (B) H44A (C) H47A (D) N69A (E) Q72A (F) K160A (G) Q164A after 50 ns MD simulations. Interaction of Mg2+ ion with ATP and PS residues is represented as “–” and H-bond as “------” respectively.
Interaction profile between PS and ATP in wild-type and alanine mutants after MD simulations.
| Systems | No. of hydrogen bond | Participating residues in hydrogen bond with their bond length (Å) | Participating residues in hydrophobic bonding |
|---|---|---|---|
| Wild-type | 16 | Arg44(2.7 Å), Arg47(2.7 Å, 2.9 Å), Gly158(2.7 Å,), Lys160(2.5 Å, 2.9 Å), Val187(3.0 Å, 3.0 Å), Met195(2.9 Å), Ser196(2.7 Å), Ser197(3.1 Å, 2.8 Å, 2.6 Å), Arg198(2.8 Å, 2.7 Å, 2.5 Å) | Gly46, Leu50, Phe157, Pro185, Thr186 |
| H44A | 13 | Arg47(2.6 Å), Lys160(2.5 Å, 3.0 Å), Asp161(2.5 Å), Val187(2.9 Å, 2.9 Å), Met195(2.9 Å), Ser196(2.7 Å), Ser197(2.9 Å, 3.0 Å), Arg198(3.2 Å, 2.6 Å, 2.5 Å) | Gly46, Phe157, Gly158, Pro185, Thr186 |
| H47A | 9 | Arg44(2.8 Å), Gly158(2.9 Å,), Lys160(2.7 Å), Val187(2.9 Å, 3.1 Å), Met195(2.9 Å), Ser196(2.6 Å), Arg198(2.6 Å, 2.5 Å) | Gly46, His47, Leu50, Phe157, Pro185, Thr186 |
| N69A | 12 | Arg44(2.6 Å), Lys160(2.9 Å, 2.6 Å, 2.9 Å), Val187(3.0 Å, 3.0 Å), Met195(3.0 Å), Ser196(2.6 Å), Ser197(2.7 Å), Arg198(2.8 Å, 2.6 Å, 2.5 Å) | Met40, Gly46, His47, Leu50, Phe157, Gly158, Thr186 |
| Q72A | 16 | Arg44(2.7 Å), Arg47(2.6 Å), Gly158(3.0 Å), Lys160(2.5 Å, 2.9 Å), Asp161(2.9 Å),Val187(2.9 Å, 2.8 Å), Met195(3.0 Å), Ser196(2.6 Å), Ser197(2.9 Å, 2.9 Å, 3.1 Å), Arg198(2.7 Å, 2.7 Å, 3.1 Å) | His44, Leu50, Phe157, Pro185, Thr186 |
| K160A | 9 | Arg44(2.6 Å), Val187(2.9 Å), Met195(2.8 Å, 3.3 Å), Ser197(3.2 Å, 2.8 Å), Arg198(2.9 Å, 2.9 Å, 2.9 Å) | Gly46, His47, Leu50, Phe157, Ala160, Pro185, Thr186 |
| Q164A | 15 | Arg44(2.6 Å), Gly158(2.9 Å, 3.3 Å), Lys160(2.5 Å, 2.8 Å), Asp161(3.2 Å) Val187(2.9 Å, 2.7 Å), Met195(3.0 Å), Ser196(2.6 Å), Ser197(2.8 Å, 3.1 Å), Arg198(2.5 Å, 2.6 Å, 3.0 Å) | Met40, His47, Leu50, Phe157, Pro185, Thr186 |
Secondary structure analysis for the conserve active residues in wild-type and alanine mutants.
| Active site residues | M40 | H44 | H47 | N69 | Q72 | K160 | Q164 |
|---|---|---|---|---|---|---|---|
|
| |||||||
| Wild-type | Coil | Coil | Helix | Coil | Turn | Turn | Helix |
| H44A | Coil | Coil | Helix | Coil | Coil | Turn | Helix |
| H47A | Strand | Turn | Turn | Coil | Turn | Turn | Helix |
| N69A | Coil | Coil | Helix | Coil | Turn | Turn | Helix |
| Q72A | Strand | Coil | Helix | Coil | Turn | Turn | Helix |
| K160A | Strand | Turn | Helix | Coil | Turn | 310helix | Helix |
| Q164A | Coil | Coil | Helix | Coil | Turn | Turn | Helix |
Interaction of active site residues in wild-type and alanine mutated complexes.
| Interactions | Wild-type | H44A | H47A | N69A | Q72A | K160A | Q164A |
|---|---|---|---|---|---|---|---|
| 44–47 | H. bond, VDW | H. bond, VDW | H. bond, VDW | H. bond, VDW | H. bond, VDW | H. bond, VDW | H. bond, VDW |
| 44–48 | H. bond | H. bond, VDW | H. bond, | H. bond, VDW | H. bond, VDW | H. bond, | H. bond, |
| 44–195 | VDW | — | VDW | — | VDW | VDW | VDW |
| 44–196 | — | — | — | — | VDW | — | VDW |
| 44–197 | H. bond | — | VDW | — | VDW | — | — |
| 47–50 | H. bond | H. bond | — | H. bond | H. bond | H. bond | H. bond |
| 47–197 | — | — | — | — | VDW | — | — |
| 69–139 | — | — | — | — | — | — | VDW |
| 72–114 | — | — | — | — | — | — | VDW |
| 72–117 | — | — | VDW | — | — | — | — |
| 72–134 | — | — | — | — | VDW | VDW | — |
| 72–135 | VDW | VDW | — | — | VDW | — | H. bond |
| 72–139 | VDW | — | — | — | — | — | VDW |
| 160–186 | — | — | VDW | VDW | — | — | — |
| 160–196 | H. bond | H. bond | — | H. bond | H. bond | — | H. bond |
| 160–194 | — | — | — | — | — | — | VDW |
| 160–195 | H. bond | H. bond | — | H. bond | H. bond | — | H. bond |
| 160–198 | — | — | — | VDW | — | — | — |
| 160–282 | — | — | — | — | H. bond | — | H. bond |
| 164–157 | VDW | — | — | — | — | — | — |
| 164–167 | — | VDW | H. bond | — | H. bond | H. bond | — |
| 164–168 | H. bond | H. bond, VDW | H. bond, VDW | H. bond | H. bond, VDW | H. bond | — |
*“VDW”: Van der Waals, “—”: not present.
Figure 5Projection of protein atoms in phase space along the first two principal eigenvectors (A) wild-type and H44A mutant (B) wild-type and H47A mutant (C) wild-type and N69A mutant (D) wild-type and Q72A mutant (E) wild-type and K160A mutant (F) wild-type and Q164A mutant.
Figure 6Cosine content of the first principal component analysis for MD simulation trajectories of wild-type and alanine mutants.
Figure 7Free energy landscape of the first two principal components for (A) wild-type (B) H44A (C) H47A (D) N69A (E) Q72A (F) K160A (G) Q164A alanine mutants.